Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

886127

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy: Infectious Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the level of screening for infectious diseases in pregnant women; and whether he plans to increase the level of that screening in (a) West Midlands and (b) Coventry.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	136322
answer	answer is ministerial correction date of answer 25/04/2018 answer text <p>There has been a steady rise in coverage in the National Health Service Infectious Diseases in Pregnancy Screening programme, from 96% in 2010 to 99% in 2016 in England.</p><p> </p><p>Coverage for University Hospitals Coventry and Warwickshire NHS Trust was 99.4% (5,960/5,994), both attaining the achievable level for a screening programme (acceptable threshold greater than or equal to 95% / achievable threshold greater than or equal to 99%).</p><p> </p><p>NHS England is responsible for commissioning antenatal screening services to meet programme standards including coverage. NHS England is working with providers to help identify and address any issues and is committed to improving coverage and reducing morbidity from this condition. It is important to note that the aim of antenatal screening is not to promote uptake but to ensure that eligible women are able to make an informed choice as to whether to participate in screening or not.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 25/04/2018 11:55:12 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	308 label Biography information for Mr Jim Cunningham

886131

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the criteria are to qualify for a medical exemption certificate to allow people not to pay for their prescriptions.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	136326
answer	answer is ministerial correction date of answer 26/04/2018 answer text <p>A person can get free National Health Service prescriptions if they have one of the medical conditions listed in regulation 10 of the National Health Service (Charges for Drugs and Appliances) Regulations 2015, and hold a valid medical exemption certificate.</p><p> </p><p>Medical exemption certificates are issued on application to people who have:</p><p>- a permanent fistula (for example, a caecostomy, colostomy, laryngostomy or ileostomy) requiring continuous surgical dressing or requiring an appliance;</p><p>- a form of hypoadrenalism (for example, Addison's disease) for which specific substitution therapy is essential;</p><p>- diabetes insipidus or other forms of hypopituitarism;</p><p>- diabetes mellitus, except where treatment is by diet alone;</p><p>- Hypoparathyroidism;</p><p>- myasthenia gravis;</p><p>- myxoedema (hypothyroidism requiring thyroid hormone replacement);</p><p>- epilepsy requiring continuous anticonvulsive therapy; and</p><p>- a continuing physical disability that means the person can't go out without the help of another person – temporary disabilities do not count, even if they last for several months.</p><p> </p><p>They are also issued for people undergoing treatment for cancer:</p><p>- including the effects of cancer; or</p><p>- the effects of current or previous cancer treatment.</p><p> </p><p>Patients can apply for a medical exemption certificate by asking their doctor for Form FP92A.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 26/04/2018 10:13:10 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

886147

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Wheelchairs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what his Department's policy is on providing electric wheelchairs for NHS patients.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	136342
answer	answer is ministerial correction date of answer 27/04/2018 answer text <p>NHS Wheelchair Services are responsible for the provision of wheelchairs, including electric wheelchairs, and are commissioned through clinical commissioning groups. Determination of the entitlement an individual has in respect of wheelchairs, or any other mobility equipment, is decided following assessment by the local NHS Wheelchair Service. Each Service will have its own assessment criteria and procedures in place in respect of eligibility for individual mobility equipment.</p><p> </p><p>Further information in relation to wheelchair and mobility services, including details in respect of all local NHS Wheelchair Services, can be located via the NHS Choices website at the following link:</p><p> </p><p><a href="https://www.nhs.uk/conditions/social-care-and-support/mobility-equipment-wheelchairs-scooters/" target="_blank">https://www.nhs.uk/conditions/social-care-and-support/mobility-equipment-wheelchairs-scooters/</a></p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 27/04/2018 10:45:46 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4131 label Biography information for Jim Shannon

886148

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effectiveness of support provided for people with dementia.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	136343
answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>In the Dementia 2020 Challenge, we have set a broad vision for transforming dementia care and support in England by 2020.</p><p> </p><p>In the accompanying Implementation Plan, which set out the actions the Department and its partners will take to ensure that the commitments in the Dementia 2020 Challenge are delivered, we set out specific actions to improve quality and levels of care. We are currently undertaking a review of the 2020 Challenge Implementation Plan to assess whether its actions have been achieved and establish what additional activity can be undertaken to ensure that the Dementia 2020 Challenge commitments are met as planned, so that England is recognised as the best country in the world for dementia care and support by 2020.</p><p> </p><p>A key commitment in the Dementia 2020 Challenge was the development of effective metrics across the health and care system to track progress. To that end, the dementia profile, which has been developed by Public Health England’s Dementia Intelligence Network, provides access to local data and intelligence across the care pathway for benchmarking purposes and to enable localities to make sustainable improvements in services and outcomes.</p><p> </p><p>To understand the experiences of people with dementia better, we have also established a Citizens’ Engagement Panel, which will be used to inform and improve the ongoing delivery of the Dementia 2020 Implementation Plan and to influence and improve the delivery of front-line dementia care services, to ensure they better meet the needs expressed by people with dementia and their carers.</p><p> </p><p>The Economic and Social Research Council and National Institute for Health Research have issued a joint funding call for projects looking at dementia prevention, interventions and care delivery. Proposals have been invited for projects that will look at care delivery across all care settings and successful projects will inform health and social care practice and policy relating to dementia, supporting people in their communities and making a difference to the lives of people with dementia and their carers and families.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 24/04/2018 12:49:15 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4131 label Biography information for Jim Shannon

886167

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Caesarean Sections
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential benefits of vaginal seeding for children born by caesarean section.
tabling member constituency	Preston
tabling member printed	Sir Mark Hendrick
uin	136362
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>At this time, the Department has made no assessment of the potential benefits of vaginal seeding for children born by caesarean section.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 23/04/2018 13:44:00 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	473 label Biography information for Sir Mark Hendrick

886206

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many women have joined the PrEP Impact trial to date.
tabling member constituency	Rotherham
tabling member printed	Sarah Champion
uin	136401
answer	answer is ministerial correction date of answer 26/04/2018 answer text <p>Since the start of the pre-exposure prophylaxis (PrEP) Impact trial in October 2017, the trial has recruited around 5,700 participants in 121 different clinics. Interim trial analysis, including reported gender of participants, will be available in winter 2018/19.</p><p> </p><p>To date, no assessment has been made of potential barriers to joining the PrEP Impact trial for women who are victims of domestic violence.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 136402 question first answered 26/04/2018 10:31:27 answering member 4067 label Biography information for Steve Brine
tabling member	4267 label Biography information for Sarah Champion

886207

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of potential barriers to joining the PrEP Impact trail for women who are victims of domestic violence.
tabling member constituency	Rotherham
tabling member printed	Sarah Champion
uin	136402
answer	answer is ministerial correction date of answer 26/04/2018 answer text <p>Since the start of the pre-exposure prophylaxis (PrEP) Impact trial in October 2017, the trial has recruited around 5,700 participants in 121 different clinics. Interim trial analysis, including reported gender of participants, will be available in winter 2018/19.</p><p> </p><p>To date, no assessment has been made of potential barriers to joining the PrEP Impact trial for women who are victims of domestic violence.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 136401 question first answered 26/04/2018 10:31:27 answering member 4067 label Biography information for Steve Brine
tabling member	4267 label Biography information for Sarah Champion

886239

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Spinal Injuries
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has conducted an impact assessment of the effect on people with spinal cord injuries resulting from the planned NHS Continuing Healthcare budget savings of £855 million by 2020-21.
tabling member constituency	Westmorland and Lonsdale
tabling member printed	Tim Farron
uin	136434
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>NHS England’s NHS Continuing Healthcare Strategic Improvement Programme aims to provide fair access to NHS Continuing Healthcare in a way which ensures better outcomes, better experience, and better use of resources.</p><p> </p><p>The programme does not aim to reduce spending on NHS Continuing Healthcare, but to reduce the rate of growth of expenditure. The projection is for spending on NHS Continuing Healthcare to increase by over 20% by 2020/21, or an average of approximately 3.9% per year.</p><p> </p><p>It is the responsibility of clinical commissioning groups to commission NHS Continuing Healthcare packages of care appropriate to the needs of individuals, and for assessing the impact of their funding decisions. Eligibility for NHS Continuing Healthcare is based on needs and is not specific to any particular condition or diagnosis.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 23/04/2018 12:23:04 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1591 label Biography information for Tim Farron

886240

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Inflammatory Bowel Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps the Government is taking to promote timely and accurate diagnosis of inflammatory bowel disease.
tabling member constituency	Great Grimsby
tabling member printed	Melanie Onn
uin	136435
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>NHS England and clinical commissioning groups (CCGs) are responsible for commissioning services for people with inflammatory bowel disease (IBD).</p><p> </p><p>To support local commissioning, the National Institute for Health and Care Excellence (NICE) has published best practice guidance for the timely and accurate diagnosis, treatment care and support for patients with IBD.</p><p> </p><p>NICE has published the guidance ’Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel’ which recommends that that faecal calprotectin testing as an option to help support clinicians distinguish between IBD and irritable bowel syndrome.</p><p> </p><p>Faecal calprotectin testing will therefore help decide who should be referred for colonoscopy (the Gold Standard diagnostic test) and who may be amenable to management in primary care. Primary and secondary care clinicians are expected to follow the good practice guidelines and the quality standard.</p><p> </p><p>NHS England commissions specialised Intestinal Failure Services. A number of these centres are currently involved in multidisciplinary training of health professionals in specialised IBD care. In addition, the Association of Coloproctology of Great Britain and Ireland are currently in the process of setting out national standards for surgical management of IBD. Patients are managed by a multidisciplinary team (MDT) with the necessary expertise to enable appropriate monitoring, support and advice necessary to manage the side effects of treatment, flare-ups and to review and maintain remission. MDT support and the associated diagnostic and investigative resource necessary for IBD patient care will usually be found in secondary care settings.</p><p> </p><p>General practitioners and clinicians are expected to take account of relevant NICE guidance to ensure that patients with suspected inflammatory bowel disease are referred quickly and efficiently, and have a specialist assessment within four weeks of referral.</p><p> </p><p>The NICE guidelines are available at the following links:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg152/resources/crohns-disease-management-pdf-35109627942085" target="_blank">www.nice.org.uk/guidance/cg152/resources/crohns-disease-management-pdf-35109627942085</a></p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg166/resources/ulcerative-colitis-management-pdf-35109695126725" target="_blank">www.nice.org.uk/guidance/cg166/resources/ulcerative-colitis-management-pdf-35109695126725</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 136439 136442 136444 question first answered 23/04/2018 15:18:40 answering member 4067 label Biography information for Steve Brine
tabling member	4464 label Biography information for Melanie Onn

886241

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the timetable is for the Electronic Prescription Service to be made available in dispensing GP practices.
tabling member constituency	Scunthorpe
tabling member printed	Nic Dakin
uin	136436
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>In December 2017, NHS Digital gave full roll out approval and assurance of a solution developed by EMIS Health to allow dispensing general practitioner (GP) practices to use the Electronic Prescription Service within their practice dispensary.</p><p> </p><p>EMIS Health supplies the EMIS Web prescribing system to approximately 50% of dispensing GP practices and will look to implement the Proscript Connect dispensing system at these sites in the first instance. This is expected to commence during summer 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/04/2018 15:17:22 answering member 4067 label Biography information for Steve Brine
tabling member	4056 label Biography information for Nic Dakin